Search For "glenmark pharmaceuticals limited"
Nirma agrees to acquire 75 per cent stake in Glenmark Life Sciences at an
Updated : 2 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 22: In a successful bid, Nirma Group has entered into definitive agreement to acquire 75 per cent of Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited at an enterprise value of about Rs 7,500 Crore, subject to closing adjustments. Ni
Read More
Glenmark Pharma announces Proposed Divestment of Majority Stake in Glenmar
Updated : 2 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 22: Glenmark Pharmaceuticals Limited ("Glenmark Pharma"), a research-led, integrated, global pharmaceutical company has entered into a definitive agreement with Nirma Limited to divest 75% stake in its subsidiary, Glenmark Life Sciences Limited ("GLS")
Read More
Glenmark Pharma reports revenue growth of 22.5 per cent, EBITDA growth of
Updated : 2 years, 7 months ago IST
Mumbai (Maharashtra) [India], August 12: Glenmark Pharmaceuticals Limited (Glenmark), an integrated, research-led, global pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2023.
Read More
Glenmark Pharma and OMRON Healthcare India team up to combat hypertension
Updated : 2 years, 7 months ago IST
Mumbai (Maharashtra) [India], August 3: Glenmark Pharmaceuticals Limited (Glenmark), a leading, integrated, research-led, global pharmaceutical company has joined hands with OMRON Healthcare India, the Indian arm of the Japanese global leader in home blood pressure monitoring and solutions f
Read More
Glenmark announces Peer Reviewed Publication of Its Phase 3 Clinical Trial
Updated : 3 years, 8 months ago IST
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee
Read More
Glenmark launches sitagliptin and its fixed-dose combinations, at affordab
Updated : 3 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 8 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched sitagliptin and its Fixed Dose Combinations (FDCs), at affordable prices for adults with Type 2 diabetes in India. The company h
Read More
Glenmark Pharma reports revenue growth of 5.6 per cent YoY Q4; 12.4 per ce
Updated : 3 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter ended March 31, 2022.
Read More
Glenmark Pharma Q4 net profit falls 26 per cent to Rs 173 crore
Updated : 3 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 28 (ANI): Glenmark Pharmaceuticals Limited on Saturday reported a net consolidated profit of Rs 172.6 crore for the quarter ended March 2022 as compared to Rs 234 crore recorded in the corresponding period of the last year, registering a decline of 26 per ce
Read More
Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin
Updated : 3 years, 11 months ago IST
Mumbai (Maharashtra) [India], April 25 (ANI/PR Newswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with
Read More
Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical
Updated : 3 years, 11 months ago IST
Mumbai (Maharashtra) [India] April 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, an innovation-driven, global pharmaceutical company, announced that its subsidiary Glenmark Specialty S.A. (Glenmark) received approval from the Indian drug regulator, Drug Controller General of India (
Read More
Glenmark Pharma reports revenue growth of 13.9% and EBITDA growth of 30.8%
Updated : 4 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 12 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a global innovation-driven pharmaceutical company, today announced its financial results for the third quarter ended December 31, 2021.
Read More
Glenmark launches Nitric Oxide Nasal Spray (FabiSpray®) in India for
Updated : 4 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 9 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) - a global, innovation-driven pharmaceutical company and Canadian pharmaceutical company SaNOtize Research & Development Corp., today announced launch of its Nitric Oxide Nasal Spray un
Read More